BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawamoto R, Nakano N, Ishikawa H, Tashiro E, Nagano W, Sano K, Irie M, Ikuta M, Kishi F, Nakane T, Naito M, Itoh S. Narciclasine is a novel YAP inhibitor that disturbs interaction between YAP and TEAD4. BBA Advances 2021;1:100008. [DOI: 10.1016/j.bbadva.2021.100008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, Zhang Y, Yu H, Zhao Y, Sun X, Li Q, Wang Y. The role of YAP1 in survival prediction, immune modulation, and drug response: A pan-cancer perspective. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1012173] [Reference Citation Analysis]
2 Diego-gonzález L, Fernández-carrera A, Igea A, Martínez-pérez A, Real Oliveira MECD, Gomes AC, Guerra C, Barbacid M, González-fernández Á, Simón-vázquez R. Combined Inhibition of FOSL-1 and YAP Using siRNA-Lipoplexes Reduces the Growth of Pancreatic Tumor. Cancers 2022;14:3102. [DOI: 10.3390/cancers14133102] [Reference Citation Analysis]